Evidence map›Paper›PMID 22768032›Full record

ArticlePloS one2012

Comprehensive biothreat cluster identification by PCR/electrospray-ionization mass spectrometry.

Rangarajan Sampath, Niveen Mulholland, Lawrence B Blyn, Christian Massire, Chris A Whitehouse, Nicole Waybright, Courtney Harter, Joseph Bogan, Mary Sue Miranda, David Smith and 17 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 5 institutions in 1 country.

Rangarajan SampathIbis Biosciences, Abbott, Carlsbad, California, United States of America. rangarajan.sampath@abbott.com
Niveen Mulholland
Lawrence B Blyn
Christian Massire
Chris A Whitehouse
Nicole Waybright
Courtney Harter
Joseph Bogan
Mary Sue Miranda
David Smith
Carson Baldwin
Mark Wolcott
David Norwood
Rachael Kreft
Mark Frinder
Robert Lovari
Irene Yasuda
Heather Matthews
Donna Toleno
Roberta Housley
David Duncan
Feng Li
Robin Warren
Mark W Eshoo
Thomas A Hall
Steven A Hofstadler
David J Ecker
Ionis Pharmaceuticals (United States) · USAbbott (United States) · USMRIGlobal · USUnited States Army Medical Research Institute of Infectious Diseases · USEnvironmental Protection Agency · US

Funding

PHS HHS 1R01-C1000099
6 · The paper itself

Abstract

Technology for comprehensive identification of biothreats in environmental and clinical specimens is needed to protect citizens in the case of a biological attack. This is a challenge because there are dozens of bacterial and viral species that might be used in a biological attack and many have closely related near-neighbor organisms that are harmless. The biothreat agent, along with its near neighbors, can be thought of as a biothreat cluster or a biocluster for short. The ability to comprehensively detect the important biothreat clusters with resolution sufficient to distinguish the near neighbors with an extremely low false positive rate is required. A technological solution to this problem can be achieved by coupling biothreat group-specific PCR with electrospray ionization mass spectrometry (PCR/ESI-MS). The biothreat assay described here detects ten bacterial and four viral biothreat clusters on the NIAID priority pathogen and HHS/USDA select agent lists. Detection of each of the biothreat clusters was validated by analysis of a broad collection of biothreat organisms and near neighbors prepared by spiking biothreat nucleic acids into nucleic acids extracted from filtered environmental air. Analytical experiments were carried out to determine breadth of coverage, limits of detection, linearity, sensitivity, and specificity. Further, the assay breadth was demonstrated by testing a diverse collection of organisms from each biothreat cluster. The biothreat assay as configured was able to detect all the target organism clusters and did not misidentify any of the near-neighbor organisms as threats. Coupling biothreat cluster-specific PCR to electrospray ionization mass spectrometry simultaneously provides the breadth of coverage, discrimination of near neighbors, and an extremely low false positive rate due to the requirement that an amplicon with a precise base composition of a biothreat agent be detected by mass spectrometry.

Indexed as

Biological Warfare AgentsBacteriaBiological AssayCluster AnalysisDNA PrimersFalse Negative ReactionsLimit of DetectionPolymerase Chain ReactionResearch ReportSensitivity and SpecificitySpectrometry, Mass, Electrospray IonizationStatistics as TopicVirusesBiological Warfare AgentsDNA Primers

Identifiers

PMID22768032
PMCPMC3387173
OpenAlexW2093572951

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.